Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LECO: Regional Blocks vs IV Lidocaine in Bariatric Surgery
NCT06793527Recruiting
- Sponsor
- Jagiellonian University
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (3 arms), sponsored by Jagiellonian University. Primary endpoint: Quality of Recovery-15 at 1 day. Started Feb 2025; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06793527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793527.